Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    80405
Show Display Options
Rank Status Study
1 Active, not recruiting Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Genetic: mutation analysis;   Other: laboratory biomarker analysis
2 Active, not recruiting Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: FOLFOX or;   Drug: FOLFIRI
3 Active, not recruiting Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Conditions: Prostate Cancer;   Breast Cancer;   Lung Cancer;   Colorectal Cancer;   Leukemia;   Multiple Myeloma
Interventions: Other: internet-based intervention;   Other: assessment of therapy complications;   Other: Questionnaire Administration

Indicates status has not been verified in more than two years